Jump to content
Invision Community
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE
META-99 SEARCH ENGINE             CONTACT US

macknene

Members
  • Content Count

    7
  • Joined

  • Last visited

Community Reputation

0 Neutral
  1. Rise in number of chronic diseases and increase in applications of therapeutic plasma exchange to drive therapeutic plasma exchange market According to TechSci Research report, “Global Therapeutic Plasma Exchange Market By Technique (Centrifugation v/s Membrane Separation), By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders), By Gender (Male v/s Female), By End Use (Hospitals, Clinics, Others), By Region, Forecast & Opportunities, 2025”, the global market for therapeutic plasma exchange is expected to grow at a brisk CAGR during the next five years. The market growth is fueled by the utility of product in research organizations as it is being continuously tested for its efficacies under different conditions. Therapeutic plasma exchange is a process to separate blood from plasma by different procedures like membrane separation or centrifugation. This is done to remove any particular disease that is present in plasma by replacing the blood with fresh frozen plasma (FFP) or albumin. The technique is called plasmapheresis which works by filtering harmful antibodies from the blood and is used in many chronic diseases, for instance, GBS (Guillain Barre Syndrome) is a type of disease where it is necessary to implement plasma exchange to save the life. However, process of plasmapheresis is quite costly which can hamper the growth of the market. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on " Global Therapeutic Plasma Exchange Market" https://www.techsciresearch.com/report/therapeutic-plasma-exchange-market/4598.html Global therapeutic plasma exchange (TPE) market is segmented based on technique, indication, gender, end use and region. Indication segment is further divided into neurological disorders, renal disorders, hematology disorders and metabolic disorders. Out of these, neurological disorders are expected to hold the lion’s share as the TPE procedure has proved itself to be quite effective in the treatment of various neurological disorders, like, Guillain Barre Syndrome (GBS). It is also used to treat severe and sudden attacks of sclerosis. American Society for Apheresis (ASFA) provides a set of regulated guidelines, which needs to be followed before using the procedure into any application. End use segment is divided into hospitals, clinics and others, out of which, hospitals held the largest share in 2019 and are expected to grow at the fastest rate during the forecast period. This growth can be attributed to the increase in the number of patients suffering from diseases that require plasmapheresis technique for their treatment. Based on regional analysis, the market has been segmented into Asia-Pacific, North America, Europe, South America and Middle East & Africa (MEA). North America held the dominant market share in 2019 on account of presence of pharma & biotech companies. Moreover, the R&D sector in this region has been developing over years, which can be held responsible for the region’s market dominance. Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4598 Customers can also request for 10% free customization on this report. Some of the leading players in global therapeutic plasma exchange market include Haemonetics Corporation, Fresenius Medical Care, Terumo BCT, Inc., Baxter International Inc., Asahi Kasei Medical Co., Ltd., Kawasumi Laboratories Inc., B. Braun Melsungen AG, HemaCare Corporation, Medica S.p.A., Cerus Corporation, Nikkiso Co., Ltd., Miltenyi Biotec, Therakos Incorporation, Fenwal Incorporation, Kaneka Corporation, etc. “In terms of regional analysis, Asia-Pacific is expected to grow at the highest CAGR in during the forecast period which can be attributed to the rising healthcare facilities in developing countries like China, India, etc. Additionally, leading market players have commenced investing in the TPE procedures, which is also fueling the growth of the market. Moreover, in the region, China led the market in 2019 and India is anticipated to grow at the highest growth rate during the forecast period on account of increasing cases of autoimmune diseases and hematology disorders in the country.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Global Therapeutic Plasma Exchange Market By Technique (Centrifugation v/s Membrane Separation), By Indication (Neurological Disorders, Renal Disorders, Hematology Disorders, Metabolic Disorders), By Gender (Male v/s Female), By End Use (Hospitals, Clinics, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global therapeutic plasma exchange market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global therapeutic plasma exchange market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
  2. High demand for treatment of diseases like cancer and orthopaedic disorders and increasing funding for research to drive global nuclear medicine market According to TechSci Research report, “Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET) By Application (Cardiology, Respiratory, Orthopaedics, Others), By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Others), By Route of Administration (Oral, Intravenous, Nasal), By End-User (Hospitals, Diagnostic Centers, Others), By Region, Forecast & Opportunities, 2025”, the market is expected to grow at a robust CAGR of 2% during forecast period owing to factors like rising incidence and prevalence of cancer and cardiovascular diseases and rising awareness about nuclear medicine. Additionally, conventional chemotherapy treatments are being replaced by therapeutic radiopharmaceuticals for oncology and cancer treatment due to their greater convenience. This is further propelling the growth of global nuclear medicine market. Additionally, nuclear Medicines works as a convenient and safer alternative for patients when compared to X-Rays and other external radiation imaging devices. Due to this, physicians nowadays are preferring nuclear medicines, which are also known as radiopharmaceuticals. Application of nuclear medicines has also helped in improving pediatric survival rate globally and hence are getting accepted widely. Moreover, advancements in radiotracers and advent of alpha radioimmunotherapy (Rit)-based targeted cancer treatments are also creating high demand for nuclear medicines. Expanding usage across neurological applications are likely to benefit nuclear medicine manufacturing companies. However, there are certain issues which nuclear medicine market faces. Lack of patient and physician education and awareness proves as a challenge for the market. Also, competition from other imaging modalities makes the nuclear medicine market highly competitive. The rival imaging modalities have been successful in being accepted among medical practitioners. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on"Global Nuclear Medicine market" https://www.techsciresearch.com/report/nuclear-medicine-market/4562.html The global nuclear medicine market is segmented based on therapy, type, application, therapeutics, route of administration, end-user and region. Based on type, the global nuclear medicine market is segmented into SPECT, PET. PET is majorly used in 80% of Oncology procedures whereas SPECT contributes majorly in applications such as, Cardiology, Nephrology and Neuroendocrine. Based on application, the market is segmented into cardiology, respiratory, orthopaedics, neurology, oncology and urology. Among them, the oncology segment holds a strong dominance in the global nuclear medicines market followed by cardiology segment. The segment holds largest market share because of the government initiatives and high adoption rate worldwide. Based on region, North America dominates the nuclear medicines market with United States being the largest consumer and Canada being the major supplier of nuclear medicines. The developments in imaging systems have played a major role in fueling the growth of the market. Key Players : Major players operating in the global nuclear medicine market include Cardinal Health, Inc., Curium SAS, Lantheus Holdings, Inc., Bracco S.p.A., Advanced Accelerator Applications SA, NTP Radioisotopes SOC Ltd, Eckert & Ziegler AG, Jubilant DraxImage, Inc., GE Healthcare, Inc., Siemens Healthineers AG, Rotem Industries Ltd., Eczacibasi Holding AS, IBA Group Ltd., Ire-Elit S.A., Lucerno Dynamics, LLC, Positron Corporation, NorthStar Medical Radioisotopes, LLC , Pharmalucence, Inc., Norgine B.V., F. Hoffmann-La Roche AG, etc. Key players are implementing multiple strategies to maintain their significant share in the global nuclear medicine market. These strategies include mergers & acquisition, product developments, business expansion and collaborative development. Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4562 Customers can also request for 10% free customization on this report. “Exponential growth in the healthcare industry is expected to fuel the nuclear medicine market across the globe. Increasing investment for research and development of nuclear medicine is going to pen myriad opportunities for the companies. However, nuclear medicines are not cost effective hence the market is relatively constrained. Some major steps which can be taken to boost the market could be educating medical practitioners and patients about the benefits of nuclear medicines,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Global Nuclear Medicine Market By Therapy (Radioactive Iodine, Radioactive Antibodies, Others), By Type (SPECT, PET), By Application (Cardiology, Respiratory, Orthopaedics, Others), By Therapeutics (Alpha Particle Emitters, Beta Particle Emitters, Others), By Route of Administration (Oral, Intravenous, Nasal), By End-User (Hospitals, Diagnostic Centers, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of nuclear medicine market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global nuclear medicine market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
  3. Increase in instances of foodborne illness due to mycotoxin contamination to drive the growth of global mycotoxin testing market According to TechSci Research report, “Global Mycotoxin Testing Market By Type (Aflatoxins, Ochratoxin, Fumonisins, Zearalenone, deoxynivalenol, Trichothecenes, Patulin, Others), By Sample (Feed & Food), By Technology (Chromatography- & Spectroscopy-Based Vs Immunoassay-Based), By Region, Forecast & Opportunities, 2025”, global mycotoxin testing market is expected to witness robust CAGR during the forecast period. Increasing population across the globe is leading to growing demand for food, which in turn makes it obligatory to emphasize more on mycotoxin testing, thereby accounting for the growth of global mycotoxin testing market. Moreover, growing health consciousness among consumers is further expected to bode well for the growth of global mycotoxin testing market through 2025. In addition to this, changing atmospheric conditions is leading to the production of mycotoxin in food products such as cereals, dried fruits, bread and cookies, herbs and species, milk and dairy products, beverages such as beer and wine, among others, which in turn is expected to positively influence the growth of global mycotoxin testing market in the years to come. Also, governments all around the globe are taking initiates to resolve the issues which are being caused by mycotoxins such as introduction of stringent regulations for the players in the food and beverage industry to follow, which is making headway for the growth of global mycotoxin testing market across the globe. Along with this, increased international trade mandates as well as food recalls is positively contributing to the market growth. Furthermore, continuous development of advanced technologies to rapidly and effectively test the presence of mycotoxins is anticipated to fuel the market through 2025. However, there are some factors that can act as major impediments to the growth of global mycotoxin testing market through 2025 such as lack of food control systems, infrastructure, technology in the emerging economies, etc. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on"Global Mycotoxin Testing Market " https://www.techsciresearch.com/report/mycotoxin-testing-market/4600.html Global mycotoxin testing market can be segmented based on type, sample, technology, company and region. Considering the sample, the market is fragmented into feed & food. The food segment dominated the global mycotoxin testing market in terms of largest market share until 2019 and is further anticipated to maintain its dominance during the forecast period as well, which can be accredited to the fact that food samples are tested more often for the presence of mycotoxins when compared to feed samples. Moreover, mycotoxins in food can have toxic effects on the host such as immunosuppression, birth defects, irritable skin, and neurotoxicity, which makes its testing necessary, thereby spurring the growth of this segment. In terms of technology, the market is fragmented into chromatography- & spectroscopy-based and immunoassay-based. Out of which, the chromatography & spectroscopy-based segment is anticipated to grow at the highest rate during the forecast period. This high growth is due to introduction of faster liquid chromatograph technologies for high-performance liquid chromatography. Key Players : SGS, Bureau Veritas, Intertek, Eurofins, Als Limited, Neogen, Asurequality, Microbac, Romer Labs, Symbio Laboratories are among others are the leading players operating in global mycotoxin testing market. The players are adopting several growth strategies to enhance the market scenario of mycotoxin testing. Other competitive strategies include product launches; mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen their market position. Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4600 customers can also request for 10% free customization on this report. “Europe is forecast to dominate the global mycotoxin testing market during the next five years on account of a reflection of food safety policies in this region by NATIONAL REFERENCE LABORATORIES (NRLs), Control Laboratories (CLs), European Food Safety Authority (EFSA), and EU Reference Laboratories (EURLs). Furthermore, growing food and feed mycotoxin testing is further anticipated to bolster the market growth until 2025.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Global Mycotoxin Testing Market By Type (Aflatoxins, Ochratoxin, Fumonisins, Zearalenone, deoxynivalenol, Trichothecenes, Patulin, Others), By Sample (Feed & Food), By Technology (Chromatography- & Spectroscopy-Based Vs Immunoassay-Based), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global mycotoxin testing market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global mycotoxin testing market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
  4. Growing prevalence of chronic kidney diseases worldwide along with shift towards sedentary lifestyles to drive the growth of global kidney function tests market According to TechSci Research report, “Global Kidney Function Tests Market By Disease (Acute, Chronic), By Diagnosis (Blood test, Imaging tests, Biopsy, Urine Tests), By Factors (High blood pressure, Diabetes, Acute kidney injury, Cardiovascular disease, Kidney stones, Enlarged prostate or lupus, Others), By Product Type (Kits and essay, Software, Instruments), By End-User (Hospitals and clinics, Diagnostic laboratories, Research Laboratories and Institutes Others), By Region, Competition, Forecast & Opportunities, 2025”, global kidney function tests market is expected to witness robust growth rate during the forecast period. Growing incidences of diabetes and hypertension is one of the major factor accounting for the growth of global kidney function tests market. Moreover, number of geriatric populations is increasing at an alarming rate, which is further expected to bode well for the growth of global kidney function tests through the forecast years. In addition to this, high incidence rate of renal fibrosis is anticipated to positively influence the growth of global kidney function tests market in the years to come. Also, shift towards sedentary lifestyle is making headway for the growth of global kidney function tests market across the globe. Moreover, technological advancements such as advanced parameter estimation, usage of automated analyzers and computer-assisted interpretation are anticipated to aid the market growth in the forecast years. However, there are some factors that can act as major impediments to the growth of global kidney function tests market through 2025 such as rise in overall stringent regulatory approvals and healthcare expenditure, high initial investment cost among others. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" Global Kidney Function Tests Market " https://www.techsciresearch.com/report/kidney-function-tests-market/4585.html Global kidney function tests market is segmented based disease, diagnosis, factors, product type, end-user, company and region. Considering the diagnosis, the market is fragmented into blood test, imaging tests, biopsy and urine tests. The urine tests segment dominated the global kidney function tests market in terms of highest revenue until 2019 and is further anticipated to hold its dominance during the forecast period as well, which can be accredited to surging use of urine dipsticks analysis. Additionally, collection of urine samples is much easier as compared to blood samples, which is further aiding the growth of the segment globally. In terms of factors, the market is fragmented into high blood pressure, diabetes, acute kidney injury, cardiovascular disease, kidney stones, enlarged prostate or lupus and others. Out of which, the increase in kidney function test due to diabetes segment is anticipated to grow at a high pace during the forecast period which can be accredited to the increase in population having diabetes across the globe as high sugar levels in the blood of a diabetic patient can cause tiny blood vessels to become narrow and clogged. Download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4585 customers can also request for 10% free customization on this report. “North America is forecast to dominate the global kidney function tests market during the next 5 years on account of mounting cases of diabetes in the United States. Moreover, Government of Canada is taking initiatives for treating kidney diseases which is also expected to contribute to the growing trend. Furthermore, Asia-Pacific region is forecast to register high growth through 2025 due to increase in research and development initiatives and funding by major market players. Moreover, growing healthcare organizations in developing economies across the region is anticipated to further fuel the market in Asia-Pacific until 2025.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Global Kidney Function Tests Market By Disease (Acute, Chronic), By Diagnosis (Blood test, Imaging tests, Biopsy, Urine Tests), By Factors (High blood pressure, Diabetes, Acute kidney injury, Cardiovascular disease, Kidney stones, Enlarged prostate or lupus, Others), By Product Type (Kits and essay, Software, Instruments), By End-User (Hospitals and clinics, Diagnostic laboratories, Research Laboratories and Institutes Others), By Region, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of global kidney function tests market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global kidney function tests market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
  5. Increased government funding and growth in number of genomics projects to drive global genome editing market until 2025 According to TechSci Research report, “Global Genome Editing Market By Technique, By Applications, By Source, By End-User, By Region, Forecast & Opportunities, 2025”, the global genome editing market is expected to witness substantial growth and is projected to grow at a robust CAGR during the forecast period owing to its application in a large number of areas, such as mutation, therapeutics, and agriculture biotechnology. The major factors propelling growth of genome editing market are increasing prevalence of cancer and other genetic disorders, prevalence of infectious and chronic diseases like hepatitis, tuberculosis, malaria and growth of biotechnology and pharmaceutical industries. The number of research activities for the treatment of chronic diseases using genome editing technology is increasing, which is further driving the market growth. Additionally, technological advancements in the biotechnology sector are giving boost to the demand for genome editing, globally. Moreover, developing countries are serving as emerging market for the growth of genome editing. This can be majorly attributed to the continuous research and development activities and funding from various research organizations. However, the global genome market also has some restraints. There are some risks and ethical issues associated with genome editing which hampers the market growth. Genetic alteration of human germline for medicinal purposes is a debatable issue. Many researchers and scientists have advocated for the ban or prohibition of genome editing fearing its illegal usage. Also, lack of skilled professionals, high equipment cost, and negative public opinion about genetic research are posing as a threat for the market growth. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" Global Genome Editing Market" - https://bit.ly/2WJ8Abn
  6. Rising demand for easy treatment methods and surging respiratory diseases to drive market for portable ventilator market globally According to TechSci Research report, “Global Portable Ventilator Market By Type, By Mode, By Application, By End User, By Region, Forecast & Opportunities, 2025”, the global market for portable ventilator is expected to grow at a steady rate during the forecast period. Ventilators find their usage in providing oxygen to the patients suffering from critical breathing and respiratory problems. In order to ease the breathing process in the circumstances where intensive care is required, ventilators play a vital role by supplying oxygen rich gas to the patient. The portable ventilator market is driven by various factors for instance, growth of ample number of respiratory and breathing diseases, increase in geriatric population, indispensable need for easy and better treatment of patients, increasing rate of smokers and installation of ventilator in ambulances and other places that require commutation. Additionally, technological advancements have led to the betterment of medical facilities and portable ventilators, due to which it is now possible to provide the right amount of pressure and oxygen needed by patient. Even though portable ventilators are highly important today, the complications of hectic installation and high maintenance cost might hamper the growth of the market during the forecast period. The urge for finance management makes people opt for cheaper products of lesser quality from local vendors, which is one of the challenges for the growth of this market. Improper ventilation cycles, inadequate or extra amount of heating, misfunctioning of alarms might also hamper the market growth. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" India Hemorrhoids Surgical Devices Market" https://www.techsciresearch.com/report/portable-ventilator-market/4541.html The global portable ventilator market is segmented based on type, mode, application, end user and region. Based on type, the market is segmented into invasive ventilation and non-invasive ventilation. The invasive ventilation segment holds the largest share because of the growing number of diseases like respiratory diseases, neurological diseases and sleeping disorders. Furthermore, the mode segment is segmented into pressure mode ventilation, volume mode ventilation and combined mode ventilation. The pressure mode ventilation segment is expected to dominate the market on account of its end-user applications in hospitals, ambulances, clinics, rehabilitation centers and others. In terms of regional analysis, the market is dominated by North America and the region is anticipated to hold its leading position until 2025, due to high hospitalization rate and highly developed healthcare system in the countries such as US & Canada. The well-developed economy of the region is also a supporting factor for the growth of the market. North America is followed by Europe because of the increasing Intensive Care Units (ICUs). However, Asia-Pacific region is expected to grow at the highest rate through 2025, due to presence of countries like China and India, where the patient population is high and so is the expense on health and hospitals. Leading players in the global portable ventilator market include Becton Dickinson and Co., ResMed Inc, Smiths Group PLC, Trivitron Healthcare Pvt Ltd, Medtronic PLC, Percussionaire Corp, Koninklijke Philips NV, Draegerwerk AG & Co KGaA, Teleflex Inc and Hamilton Medical AG, etc. The companies tend to be competitive with each other and hence to expand their market share and size and in order to gain the maximum profit, they keep launching new and improved portable ventilators with advanced and quality features. “Global portable ventilator market is anticipated to witness substantial growth in the next five years as today the technology has intervened in different verticals like automotive, ICT, power, consumer goods & retail, and especially medical and healthcare, due to which, portable ventilators would assist significantly in saving more lives by being an essential part of ambulances and providing enhanced features of operations in critical circumstances.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4541 Customers can also request for 10% free customization on this report. “Global Portable Ventilator Market By Type, By Mode, By Application, By End User, By Region, Forecast & Opportunities, 2025”, has evaluated the future growth potential of global portable ventilator market and provided statistics & information on market size, shares, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global portable ventilator market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
  7. Increasing adoption of point of care testing is expected to drive growth of global clinical diagnostics market According to TechSci Research report, “Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays, Hybridization, DNA Diagnostics, Others), Microbiology, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025”, the global clinical diagnostics market is expected to grow at a formidable rate during the forecast period on account of the growing awareness among the patients pertaining to different types of diagnostic tests and procedures. Additionally, increased adoption of automated platforms in the healthcare industry is expected to propel the market during the next five years. Furthermore, increase in the number of diagnostic centers, point of care testing centers, hospitals, among others is adding to and enhancing the quality of existing healthcare services across the globe, which is further projected to promote the market growth over the course of next five years. Moreover, supportive government policies & schemes for spreading awareness pertaining to various diseases and their diagnosis is expected to foster the growth of market across the globe. Additionally, governments across various economies are heavily investing in the healthcare industry and R&D activities for development of specialty drugs. However, affordability issues associated with high-end diagnostics can hamper the growth of market during forecast period. Additionally, stringent government regulations on the manufacturing of diagnostic products are also expected to slow down the growth of market. Furthermore, inadequate and tedious reimbursement procedures are also negatively impacting the growth of market during the next five years. Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on" Global Clinical Diagnostics Market" https://www.techsciresearch.com/report/clinical-diagnostics-market/4519.html The global clinical diagnostics market is segmented based on type of test, product, technique, application, end user and region. Based on product, the market can be categorized into instruments, reagents and software & services. The instruments segment is expected to witness significant growth during the forecast period on account of the ongoing technological advancements and innovations in this segment. Based on technique, the market can be fragmented into immunodiagnostics (ELISA, western blot, radioimmunoassay, hematology, others), molecular diagnostics (PCR, microarrays, hybridization, DNA diagnostics, others), microbiology, tissue diagnostics, clinical chemistry and others. The immunodiagnostics segment is expected to dominate the market through 2025. This can be accredited to the increasing adoption of immunoassay based POC testing and rapid testing. On the contrary, the molecular diagnostics segment is expected to register significant growth in the market owing to the increasing approval grants by various regulatory agencies. Based on application, the market can be grouped into infectious diseases (sepsis, respiratory diseases, gastrointestinal diseases, nephrological diseases, new corona virus (COVID-19), AIDS & hepatitis), antimicrobial resistance & health associated infections (antimicrobial resistance, HAIs, others), cardiovascular emergencies, personalized medicine and others (industrial applications (agri-food sector, biopharma, cosmetics)). The infectious disease segment is expected to dominate the market on account of the growing prevalence of infectious diseases such as TB, AIDs, among others. Based on end user, the market can be segmented into hospital, diagnostic laboratory, point-of-care testing, academic & medical schools and others. The hospitals segment is expected to dominate the market during the forecast period. This can be ascribed to the high demand for diagnostic tests as a result of increase in number of hospitalization cases for diagnosis of critical ailments. Abbott Laboratories, bioMérieux, Bio-Rad Laboratories Inc., Danaher Corporation, Becton, Dickinson and Company, Qiagen, Roche Diagnostics, Thermo Fisher Scientific, Inc., Sysmex Corporation and others are some of the leading players operating in global clinical diagnostics market. The companies operating in the market are using organic strategies such as product launches, mergers and collaborations to boost their share. For instance, in November 2018, Roche Diagnostics launched VENTANA pan-TRK (EPR17341) Assay for global distribution. It is the first automated IVD immunohistochemistry assay used for the detection of tropomyosin receptor kinase in cancer patients. For instance, in August 2018, Sysmex Corporation and JVC Kenwood Corporation agreed to jointly establish a new company Creative Nano systems Corporation to develop and manufacture biodevices. Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4519 Customers can also request for 10% free customization on this report. “Asia-Pacific is expected to witness significant growth in the clinical diagnostics market during the forecast period, owing to the increasing prevalence of chronic diseases and ageing population. Additionally, growing pollution levels in countries like India and China has increased the chances for outburst of severe diseases, thereby resulting in increased demand for diagnostic services and preventive care. Furthermore, technological advancements have led the diagnostic sector growing and evolving very rapidly in the region, which can further strengthen the diagnostics sector in the healthcare system and make diagnostic services available to general population at affordable prices.” said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm. “Global Clinical Diagnostics Market Type of Test (Lipid Panel, Metabolic Panel, Liver Panel, Renal Panel, Complete Blood Count, Electrolyte Testing, Infectious Disease Testing, Others), By Product (Instruments, Reagents, Software & Services), By Technique (Immunodiagnostics (ELISA, Western Blot, Radioimmunoassay, Hematology, Others), Molecular Diagnostics (PCR, Microarrays, Hybridization, DNA Diagnostics, Others), Microbiology, Tissue Diagnostics, Clinical Chemistry, Others), By Application (Infectious Diseases (Sepsis, Respiratory Diseases, Gastrointestinal Diseases, Nephrological Diseases, New Corona Virus (COVID-19), AIDS & Hepatitis), Antimicrobial Resistance & Health Associated Infections (Antimicrobial Resistance, HAIs, Others), Cardiovascular Emergencies, Personalized Medicine, Others(Industrial Applications (Agri-food sector, Biopharma, Cosmetics)), By End User (Hospital, Diagnostic Laboratory, Point-of-Care Testing, Academic & Medical Schools, Others), By Region, Forecast & Opportunities, 2025” has evaluated the future growth potential of global clinical diagnostics market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in global clinical diagnostics market. Contact Mr. Ken Mathews 708 Third Avenue, Manhattan, NY, New York – 10017 Tel: +1-646-360-1656 Email: sales@techsciresearch.com
×
×
  • Create New...